BI

BVF Inc Portfolio holdings

AUM $2.8B
This Quarter Return
+21.94%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$2.74B
AUM Growth
+$2.74B
Cap. Flow
+$297M
Cap. Flow %
10.84%
Top 10 Hldgs %
49.25%
Holding
82
New
4
Increased
18
Reduced
6
Closed
10

Top Buys

1
PTGX icon
Protagonist Therapeutics
PTGX
$86.8M
2
GLPG icon
Galapagos
GLPG
$79.8M
3
IONS icon
Ionis Pharmaceuticals
IONS
$51.4M
4
GPCR icon
Structure Therapeutics
GPCR
$41.6M
5
RVMD icon
Revolution Medicines
RVMD
$36.8M

Top Sells

1
RCUS icon
Arcus Biosciences
RCUS
$47.6M
2
CGEM icon
Cullinan Oncology
CGEM
$44.1M
3
VRDN icon
Viridian Therapeutics
VRDN
$27.2M
4
CNCE
Concert Pharmaceuticals, Inc.
CNCE
$21.2M
5
ANNX icon
Annexon
ANNX
$19.5M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SLN
51
Silence Therapeutics
SLN
$237M
$9.35M 0.34%
1,508,416
– –
CDTX icon
52
Cidara Therapeutics
CDTX
$1.61B
$8.71M 0.32%
343,056
– –
NLSP icon
53
NLS Pharmaceutics
NLSP
$9.96M
$8.68M 0.32%
143,678
– –
VSTM icon
54
Verastem
VSTM
$585M
$7.9M 0.29%
1,585,221
– –
ALPN
55
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$6.63M 0.24%
858,339
-277,601
-24% -$2.14M
VIRX
56
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$5.75M 0.21%
3,614,662
– –
ELDN icon
57
Eledon Pharmaceuticals
ELDN
$155M
$5.49M 0.2%
2,326,710
– –
PVLA
58
Palvella Therapeutics, Inc. Common Stock
PVLA
$592M
$4.96M 0.18%
63,504
– –
ELEV
59
DELISTED
Elevation Oncology
ELEV
$4.39M 0.16%
2,312,200
– –
VRDN icon
60
Viridian Therapeutics
VRDN
$1.59B
$4.27M 0.16%
168,000
-1,070,974
-86% -$27.2M
HLVX icon
61
HilleVax
HLVX
$105M
$4.11M 0.15%
248,579
– –
MOLN
62
Molecular Partners
MOLN
$139M
$2.66M 0.1%
443,221
– –
IVA
63
Inventiva
IVA
$802M
$2.5M 0.09%
686,040
– –
WHWK
64
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
$2.3M 0.08%
318,205
-244,104
-43% -$1.77M
MTEM
65
DELISTED
Molecular Templates, Inc.
MTEM
$1.9M 0.07%
333,104
– –
IMUX icon
66
Immunic
IMUX
$79.4M
$1.71M 0.06%
1,149,425
– –
CRVS icon
67
Corvus Pharmaceuticals
CRVS
$419M
$1.25M 0.05%
1,370,947
– –
INFI
68
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$1.02M 0.04%
6,353,645
– –
ELTX icon
69
Elicio Therapeutics
ELTX
$169M
$621K 0.02%
107,130
– –
GLMD icon
70
Galmed Pharmaceuticals
GLMD
$7.07M
$575K 0.02%
7,488
-2,177
-23% -$167K
RZLT icon
71
Rezolute
RZLT
$630M
$366K 0.01%
190,815
– –
NEUP
72
Neuphoria Therapeutics Inc. Common Stock
NEUP
$22.5M
$211K 0.01%
6,748
– –
ANNX icon
73
Annexon
ANNX
$225M
– –
-3,780,694
Closed -$19.5M
COGT icon
74
Cogent Biosciences
COGT
$1.83B
– –
-984,824
Closed -$11.4M
GBIO icon
75
Generation Bio
GBIO
$40.3M
– –
-10,290
Closed -$404K
1 2
3
4